FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

FDA Clears MiRus Europa Pedicle Screw System

FDA clears a MiRus 510(k) for the MoRe-based Europa Pedicle Screw System, which the company says is the first cleared medical device with this new cla...

iMedDo Selling Unapproved, Misbranded Drugs: FDA

FDA warns the iMedDo Web site that it is selling unapproved and misbranded human and animal drugs.

Human Drugs

Clarus Therapeutics Oral Testosterone Approved

FDA approves a Clarus Therapeutics NDA for Jatenzo (testosterone undecanoate), an oral testosterone capsule to treat men with certain forms of hypogon...

Medical Devices

Innovative Neurologicals Electrotherapy Stimulator Cleared

FDA clears an Innovative Neurological Devices 510(k) for the Cervella Cranial Electrotherapy Stimulator for treating anxiety, depression, and insomnia...

Human Drugs

CGMP Violations at Thibiant International

FDA warns Thibiant International about CGMP violations in its production of finished pharmaceuticals.

Biologics

Janssen Pharma sBLA for Darzalex in Multiple Myeloma

Janssen Pharmaceutical files a supplemental BLA seeking approval of Darzalex (daratumumab) in combination with bortezomib, thalidomide and dexamethaso...

Federal Register

Info Collection Extension for CLIA Waiver Apps

Federal Register notice: FDA seeks comments on an information collection extension for Clinical Laboratory Improvement Amendments (CLIA) of 1988 waive...

Federal Register

Guide on Standards in CBER Submissions

Federal Register notice: FDA makes available a final guidance entitled Standards Development and the Use of Standards in Regulatory Submissions Review...

Medical Devices

Least Burdensome Guidance Outlined

CDER regulatory advisor Joshua Silverstein uses a Webinar to describe provisions in the final guidance on the least burdensome approach to regulatory ...

Biologics

FDA Promoting Blood Pathogen Reduction Means

FDA commissioner Scott Gottlieb and CBER director Peter Marks describe agency steps to develop a technology to reduce blood pathogens.